Correlation Between Akero Therapeutics and Prometheus Biosciences

Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akero Therapeutics and Prometheus Biosciences, you can compare the effects of market volatilities on Akero Therapeutics and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Prometheus Biosciences.

Diversification Opportunities for Akero Therapeutics and Prometheus Biosciences

0.73

Correlation Coefficient

Akero Therapeutics  Prometheus Biosciences

Poor diversification

The 3 months correlation between Akero and Prometheus is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Prometheus Biosciences go up and down completely randomly.

Pair Corralation between Akero Therapeutics and Prometheus Biosciences

If you would invest  2,599  in Akero Therapeutics on September 2, 2024 and sell it today you would earn a total of  611.00  from holding Akero Therapeutics or generate 23.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	1.56%
Values	Daily Returns

Akero Therapeutics  vs.  Prometheus Biosciences

Akero Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Prometheus Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prometheus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Prometheus Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Akero Therapeutics and Prometheus Biosciences

The main advantage of trading using opposite Akero Therapeutics and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.

The idea behind Akero Therapeutics and Prometheus Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.